News

GBI Research: Opioid market to surpass $17 billion by 2021

BY David Salazar
LONDON — GBI Research published a report Thursday that noted the U.S. market for opioids will be growing in the coming years. According to the report, the opioid market will hit $17.7 billion by 2021, up from $11 billion in 2014, with a compound annual growth rate of 7%. 
 
The report attributes the growth to a concurrent increase in chronic pain in the United States, stemming from an aging population and more incidences of such chronic diseases as diabetes, obesity, cancer, arthritis and cardiovascular disease. 
 
“Approximately 116 million Americans experienced chronic pain in 2014, which is higher than the incidence of diabetes, heart disorders and cancer combined, and as many as 25 million people experienced moderate to severe pain with significant pain-related activity limitations and diminished quality of life,” GBI Research analyst Deekshita Allavarapu said. 
 
The report comes amid new measures aimed at curbing opioid abuse from the Obama administration and new clinical guidelines that seek to reduce the number of opioids prescribed. However, though this might mean difficulty for manufacturers of opioids, it also presents opportunities for businesses that want to make drugs harder to abuse. 
 
“The result of these possible market restrictions, however, is that opportunities may open up for the development of abuse-deterrent opioids and of products that treat or prevent overdoses,” Allavarapu  said. “Such drugs include Naloxone, which reverses the effect of opioid overdose, Remoxy, a form of controlled-release oxycodone, and Embeda, which combines morphine with an antagonist to reduce the effects of the morphine if necessary.”
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Escalating use behind Amazon.com tripling of Dash Button offering

BY Michael Johnsen
SEATTLE – Amazon.com on Thursday tripled the number of brands that can be replenished through the online retailer's Amazon Dash Button, including new brands like Doritos, Energizer, Red Bull and Starbucks. Even Trojan can now be re-ordered through Amazon. 
 
And with good reason, Amazon's Dash Button orders have grown by more than 75% in the last three months and now take place more than once a minute, the retailer reported. 
 
"We’re thrilled with the positive response we’ve seen for Dash Buttons — and we heard loud and clear from customers that they wanted more brands, more categories and more products in the program. We’re excited to now offer over 100 Dash Buttons representing top-name brands across dozens of retail categories and thousands of product options,” stated Daniel Rausch, director of Amazon Dash. 
 
“Dash Button makes shopping easy, and fun. We’ve seen great engagement from our customers and are excited to bring more brands to the Dash Button lineup, including favorites like Lysol, Airborne and Air Wick,” commented Taryn Mitchell, global VP Digital Sales, Reckitt Benckiser.
 
Dash Buttons are available to Prime members for $4.99 each, and they’re essentially free — with the first order through a Dash Button, members receive a $4.99 credit to their Amazon account. When a customer is running low on one of their everyday essentials, they can simply press a Dash Button to automatically reorder the item with free Prime shipping. 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Flu incidence abating in Oregon, California according to latest Walgreens Flu Index report

BY Michael Johnsen
DEERFIELD, Ill. – The incidence of flu is beginning to abate across California and Oregon, according to the latest Walgreens Flu Index report. However, flu activity is still relatively high across Wyoming, Montana and Kentucky, according to the report. 
 
The top 10 markets with flu activity for the week of March 27 were: 
 
  1. El Paso, Texas (Las Cruces, N.M.);
  2. Harlingen – Weslaco – Brownsville – McAllen, Texas;
  3. Louisville, Ky.;
  4. Beaumont – Port Arthur, Texas;
  5. Columbus – Tupelo – West Point – Houston, Miss.;
  6. Paducah, Ky. – Cape Girardeau, Mo. – Harrisburg, Ill.;
  7. Houston;
  8. Albuquerque-Santa Fe, N.M.;
  9. Chattanooga, Tenn.; and
  10. Lincoln & Hastings –Kearney, Neb.
 
The top 10 markets with flu activity gains during that time period were: 
 
  1. Waco-Temple-Bryan, Texas;
  2. Albany-Schenectady-Troy, N.Y.;
  3. Shreveport, La.;
  4. Traverse City-Cadillac, Mich.;
  5. Austin, Texas;
  6. Joplin, Mo.-Pittsburg, Kan.;
  7. Wichita-Hutchinson, Kan.;
  8. Springfield, Mo.;
  9. Yakima-Pasco-Richland-Kenneiwck, Wash.; and
  10. Wilmington, N.C.
 
The Walgreens Flu Index does not provide data measuring actual levels or severity of flu activity, but rather, illustrates which populations are experiencing the most incidences each week based on Index methodology.
 
The Walgreens Flu Index is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens locations nationwide. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?